Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years because of the United States' request for sensitive data.
This move was revealed following a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
A government representative has since clarified that the United States was demanding access to genetic material for scientific study and profit but was unwilling to guarantee the benefits from future medical innovations.
"We are forced to start the difficult and regrettable task of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for further dialogue to secure a agreement acceptable to both sides so the nation's critical HIV programme can proceed.
Wider Implications
This development comes after a similar situation in neighbouring Kenya, where a court suspended a similar health funding agreement after concerns were raised about the security of Kenyans' medical information.
After returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had overseen aid for the American government, but Trump stated its expenditure was "wasteful" and his administration was seeking government-to-government deals to boost openness and accountability.
As per reports, Sixteen nations in Africa have so far signed similar health pacts, representing over $18.3bn in new funding.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy via American-funded initiatives," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to share its biological resources and data for a long time, with no corresponding assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Put simply, our country would supply the raw materials for medical research with no assurance that the end products would be available to our citizens should a new health crisis emerge."
National Interest and Global Health
He also noted that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting systems already established through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme designed to manage future global health emergencies.
"This framework is intended to guarantee that when a nation provides its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.
"We encourage ongoing discussions with our American counterparts on how future collaboration might be structured in a way that respects the independence and interests of each country."
Medical Community Reaction
A leading public health body said it recognised the government's concerns, but urged that talks should continue given that much of the country's Aids initiatives depended on external financing.
"Where specific concerns exist, including those involving data governance or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," it commented.
The halted deal highlights the ongoing debate between receiving vital international aid and safeguarding national sovereignty in an ever more interconnected world.